Technical Analysis for ORGO - Organogenesis Holdings Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Calm After Storm | Range Contraction | -2.70% | |
Wide Bands | Range Expansion | -2.70% | |
Calm After Storm | Range Contraction | 0.76% | |
Upper Bollinger Band Walk | Strength | 0.76% | |
Wide Bands | Range Expansion | 0.76% | |
Upper Bollinger Band Walk | Strength | 2.85% | |
Inside Day | Range Contraction | 2.85% | |
Wide Bands | Range Expansion | 2.85% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 22 hours ago |
Down 3% | about 22 hours ago |
Down 2 % | about 22 hours ago |
Down 1% | about 22 hours ago |
Up 1% | about 22 hours ago |
Get a Trading Assistant
- Earnings date: 11/12/2024
Organogenesis Holdings Inc. Description
Organogenesis Holdings Inc., a regenerative medicine company, focuses on the development, manufacture, and commercialization of solutions for the advanced wound care, and surgical and sports medicine markets primarily in the United States. The company's advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for treating DFUs; PuraPly AM to address biofilm across a range of wound types; and Affinity and NuShield to address various wound sizes and types. Its surgical and sports medicine products comprise ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical applications in targeted soft tissue repairs; and PuraPly AM for the surgical treatment of open wounds. The company's pipeline products include TransCyte for the treatment of second- and third-degree burns; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; Novachor for the treatment of chronic and acute wounds; Gintuit for the treatment of mucogingival conditions in adults; and PuraPly XT and PuraPly MZ for the treatment of chronic and acute wounds, as well as for surgical treatment of open wounds. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices. The company sells its products through direct sales representatives and independent agencies. Organogenesis Holdings Inc. was founded in 1985 and is headquartered in Canton, Massachusetts.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Clinical Medicine Organ Systems Surgery Wound Regenerative Medicine Spine Ulcer Acute Pain Burns First Aid Sports Medicine Collagen Medicine Products Surgical Treatment Wound Care Products Surgical Applications Venous Leg Ulcers Venous Ulcer Wound Bed Preparation
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.705 |
52 Week Low | 2.165 |
Average Volume | 519,421 |
200-Day Moving Average | 2.90 |
50-Day Moving Average | 3.11 |
20-Day Moving Average | 3.35 |
10-Day Moving Average | 3.78 |
Average True Range | 0.27 |
RSI (14) | 63.50 |
ADX | 37.39 |
+DI | 32.76 |
-DI | 7.08 |
Chandelier Exit (Long, 3 ATRs) | 3.75 |
Chandelier Exit (Short, 3 ATRs) | 3.57 |
Upper Bollinger Bands | 4.36 |
Lower Bollinger Band | 2.34 |
Percent B (%b) | 0.81 |
BandWidth | 60.33 |
MACD Line | 0.29 |
MACD Signal Line | 0.21 |
MACD Histogram | 0.0779 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.35 | ||||
Resistance 3 (R3) | 4.37 | 4.26 | 4.29 | ||
Resistance 2 (R2) | 4.26 | 4.17 | 4.25 | 4.26 | |
Resistance 1 (R1) | 4.12 | 4.11 | 4.06 | 4.10 | 4.24 |
Pivot Point | 4.01 | 4.01 | 3.98 | 4.00 | 4.01 |
Support 1 (S1) | 3.86 | 3.91 | 3.81 | 3.84 | 3.70 |
Support 2 (S2) | 3.76 | 3.85 | 3.75 | 3.68 | |
Support 3 (S3) | 3.61 | 3.76 | 3.65 | ||
Support 4 (S4) | 3.59 |